• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

Introduction to N,2-dimethyl-2-phenylpropanamide (CAS No. 58265-39-7)

N,2-dimethyl-2-phenylpropanamide, a compound with the chemical formula C₁₂H₁₇NO, is a significant molecule in the field of pharmaceutical chemistry and bioorganic synthesis. This compound, identified by its CAS number 58265-39-7, has garnered attention due to its structural properties and potential applications in drug development. The presence of both amide and alkyl groups in its molecular structure makes it a versatile intermediate in the synthesis of more complex pharmaceutical agents.

The amide functional group in N,2-dimethyl-2-phenylpropanamide plays a crucial role in its chemical behavior. Amides are known for their stability and reactivity, which makes them valuable in the synthesis of various bioactive molecules. The specific arrangement of the methyl and phenyl groups around the amide bond contributes to the compound's unique physicochemical properties, such as solubility and metabolic stability.

Recent advancements in medicinal chemistry have highlighted the importance of amide-containing compounds in the development of new drugs. N,2-dimethyl-2-phenylpropanamide has been studied for its potential role as a precursor in the synthesis of non-peptide analogs that mimic the activity of natural peptides. These non-peptide analogs are particularly valuable in targeting receptors and enzymes that are difficult to reach with traditional peptide-based therapies.

In addition to its pharmaceutical applications, N,2-dimethyl-2-phenylpropanamide has shown promise in materials science. Its ability to form stable complexes with other molecules makes it a candidate for use in polymer chemistry and as a ligand in catalytic systems. The compound's aromatic ring and alkyl chains contribute to its ability to interact with a wide range of substrates, making it a versatile building block for synthetic chemists.

The synthesis of N,2-dimethyl-2-phenylpropanamide typically involves the reaction of phenylacetonitrile with isobutylamine under acidic conditions. This reaction proceeds via nucleophilic addition followed by dehydration to form the amide bond. The choice of solvents and catalysts can significantly influence the yield and purity of the product. Recent studies have explored greener solvents and catalytic systems to improve the sustainability of this synthesis.

The biological activity of N,2-dimethyl-2-phenylpropanamide has been explored in several preclinical studies. Researchers have investigated its potential as an antagonist for certain neurotransmitter receptors, which could have implications in treating neurological disorders. The compound's ability to cross the blood-brain barrier makes it an attractive candidate for central nervous system (CNS) drug development. Additionally, its structural similarity to known bioactive molecules suggests that it may have additional therapeutic applications that are yet to be discovered.

The pharmacokinetic properties of N,2-dimethyl-2-phenylpropanamide are also of interest. Studies have shown that this compound exhibits moderate oral bioavailability and a reasonable half-life in vivo. These characteristics make it suitable for once or twice daily dosing regimens, which would enhance patient compliance. Furthermore, its metabolic profile suggests that it is primarily metabolized by cytochrome P450 enzymes, which is important information for drug-drug interaction studies.

In conclusion, N,2-dimethyl-2-phenylpropanamide (CAS No. 58265-39-7) is a multifaceted compound with significant potential in both pharmaceutical and materials science applications. Its unique structural features make it a valuable intermediate in drug synthesis, while its biological activity suggests therapeutic benefits in various disease areas. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in future drug development efforts.

• 957-51-7(Diphenamid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)